Bristol-Myers Squibb has ended a $3.1 billion strategic collaboration with Eisai focusing on antibody-drug conjugates (ADCs) and returned rights to the lead drug in the alliance. Eisai said in a ...
An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA. The coveted designation for GSK5764227 ...
Ceramic resonators offer an attractive alternative to quartz crystals for stabilizing oscillation frequencies in many ...
The Meze Audio 99 Classics 2nd Gen, much like the first-gen model, are a set of wired headphones with little in the way of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback